pH-triggered microparticles for peptide vaccination

被引:61
作者
Haining, WN
Anderson, DG
Little, SR
von Berwelt-Baildon, MS
Cardoso, AA
Alves, P
Kosmatopoulos, K
Nadler, LM
Langer, R
Kohane, DS
机构
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Inst Gustave Roussy, Inst Natl Sante & Rech Med 487, Paris, France
[3] Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA
[4] Univ Cologne, Dept Hematol & Oncol, Cologne, Germany
[5] MIT, Dept Chem Engn, Cambridge, MA 02139 USA
[6] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA
[7] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA
关键词
D O I
10.4049/jimmunol.173.4.2578
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Improving vaccine delivery to human APCs is a way to increase the CTL response to vaccines. We report the use of a novel pH-triggered microparticle that exploits the ability of APCs to cross-present MHC I-restricted Ags that have been engulfed in the low pH environment of the phagosome. A model MHC class I-restricted peptide Ag from the influenza A matrix protein was encapsulated in spray-dried microparticles composed of dipalmitoylphosphatidylcholine and the pH-sensitive polymethacrylate Eudragit E100. Release of the peptide from the particle was triggered by a drop in pH to the acidity normally found in the phagosome. The particles were efficiently phagocytosed by human monocytes and dendritic cells with minimal cellular toxicity and no functional impairment. Encapsulation of the peptide in the microparticles resulted in efficient presentation of the peptide to CD8(+) T cells by human dendritic cells in vitro, and was superior to unencapsulated peptide or peptide encapsulated in an analogous pH-insensitive particle. Vaccination of human HLA-A*0201 transgenic mice with peptide encapsulated in pH-triggering microparticles resulted in priming of CTL responses. These microparticles can be modified to coencapsulate a range of adjuvants along with the Ag of interest. Encapsulation of MHC I epitopes in pH-triggered microparticles increases Ag presentation and may improve CD8(+) T cell priming to peptide vaccines against viruses and cancer.
引用
收藏
页码:2578 / 2585
页数:8
相关论文
共 50 条
  • [1] Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens
    Ackerman, AL
    Kyritsis, C
    Tampé, R
    Cresswell, P
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (22) : 12889 - 12894
  • [2] Tuftsin-bearing liposomes in treatment of macrophage-based infections
    Agrawal, AK
    Gupta, CM
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2000, 41 (02) : 135 - 146
  • [3] Alves PMS, 2003, CANCER RES, V63, P8476
  • [4] Programmed contraction of CD8+ T cells after infection
    Badovinac, VP
    Porter, BB
    Harty, JT
    [J]. NATURE IMMUNOLOGY, 2002, 3 (07) : 619 - 626
  • [5] Large porous particles for sustained protection from carbachol-induced bronchoconstriction in guinea pigs
    Ben-Jebria, A
    Chen, DH
    Eskew, ML
    Vanbever, R
    Langer, R
    Edwards, DA
    [J]. PHARMACEUTICAL RESEARCH, 1999, 16 (04) : 555 - 561
  • [6] CROSS-PRIMING FOR A SECONDARY CYTOTOXIC RESPONSE TO MINOR H-ANTIGENS WITH H-2 CONGENIC CELLS WHICH DO NOT CROSS-REACT IN CYTOTOXIC ASSAY
    BEVAN, MJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1976, 143 (05) : 1283 - 1288
  • [7] In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination
    Bonifaz, LC
    Bonnyay, DP
    Charalambous, A
    Darguste, DI
    Fujii, SI
    Soares, H
    Brimnes, MK
    Moltedo, B
    Moran, TM
    Steinman, RM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (06) : 815 - 824
  • [8] Antigen density presented by dendritic cells in vivo differentially affects the number and avidity of primary, memory, and recall CD8+ T cells
    Bullock, TNJ
    Mullins, DW
    Engelhard, VH
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 170 (04) : 1822 - 1829
  • [9] Inducible Hsp70 as target of anticancer immunotherapy:: Identification of HLA-A*0201-restricted epitopes
    Faure, O
    Graff-Dubois, S
    Bretaudeau, L
    Derré, L
    Gross, DA
    Alves, PMS
    Cornet, S
    Duffour, MT
    Chouaib, S
    Miconnet, I
    Grégoire, M
    Jotereau, F
    Lemonnier, FA
    Abastado, JP
    Kosmatopoulos, K
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2004, 108 (06) : 863 - 870
  • [10] Firat H, 1999, EUR J IMMUNOL, V29, P3112, DOI 10.1002/(SICI)1521-4141(199910)29:10<3112::AID-IMMU3112>3.0.CO